BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Broquetas T, Carrión JA. Past, present, and future of long-term treatment for hepatitis B virus. World J Gastroenterol 2023; 29(25): 3964-3983 [PMID: 37476586 DOI: 10.3748/wjg.v29.i25.3964]
URL: https://www.wjgnet.com/1007-9327/full/v29/i25/3964.htm
Number Citing Articles
Zi-Hong Bao, Zhi-Kun Dai, Hao-Xian Tang. Antiviral treatment standards for hepatitis B: An urgent need for expansionWorld Journal of Gastroenterology 2024; 30(4): 418-420 doi: 10.3748/wjg.v30.i4.418
Yiqi Xiong, Wenying Qiao, Qi Wang, Kang Li, Ronghua Jin, Yonghong Zhang. Construction and validation of a machine learning-based nomogram to predict the prognosis of HBV associated hepatocellular carcinoma patients with high levels of hepatitis B surface antigen in primary local treatment: a multicenter studyFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1357496
Samuel W. Gillespie, Athreya S. Reddy, Dana M. Burris, S. Hasan Naqvi, Siddappa N. Byrareddy, Christian L. Lorson, Kamal Singh. Islatravir: evaluation of clinical development for HIV and HBVExpert Opinion on Investigational Drugs 2024; 33(2): 85 doi: 10.1080/13543784.2024.2305130
Fabiola Di Dato, Raffaele Iorio. Expanding indications for chronic hepatitis B treatment: Is it really desirable to treat everyone?World Journal of Gastroenterology 2024; 30(17): 2294-2297 doi: 10.3748/wjg.v30.i17.2294